BackAMGEN Overview
AMGEN Inc.

AMGEN Target Price

Analysts' average 12-month price target for AMGEN is $370.

Get informed when a big investor buys or sells

+ Follow

Share Price

$417.84

Average Target Price

$371.6811% downside

19 analysts in the last 4 months

High: $450 | Low: $230

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-06Bernstein$34517.4% downsideOpen
2026-08-05ScotiabankLouise Chen$4507.7% upsideOpen
2026-08-05Oppenheimer$4507.7% upsideOpen
2026-08-05RBC Capital$4004.3% downsideOpen
2026-08-05Robert W. BairdBrian Skorney$23045% downsideOpen
2026-08-05Canaccord GenuityGary Nachman$3848.1% downsideOpen
2026-08-05BMO CapitalEvan Seigerman$4507.7% upsideOpen
2026-07-29BarclaysEmily Field$36013.8% downsideOpen
2026-07-13UBS$4200.5% upsideOpen
2026-07-13Guggenheim$34317.9% downsideOpen
2026-07-08Morgan Stanley$33320.3% downsideOpen
2026-07-01BMO CapitalEvan David Seigerman$4004.3% downsideOpen
2026-06-16Mizuho SecuritiesSalim Syed$30327.5% downsideOpen
2026-06-09Morgan Stanley$34018.6% downsideOpen
2026-06-05Goldman Sachs$3896.9% downsideOpen
2026-05-14Piper Sandler$4272.2% upsideOpen
2026-05-04Guggenheim$34018.6% downsideOpen
2026-05-01Morgan Stanley$33220.5% downsideOpen
2026-04-20Canaccord Genuity$36612.4% downsideOpen
2026-04-10Morgan StanleyTerence Flynn$32622% downsideOpen
2026-04-09Guggenheim$35116% downsideOpen
2026-04-08Truist Financial$32522.2% downsideOpen
2026-03-10JefferiesAkash Tewari$35016.2% downsideOpen
2026-03-05Leerink PartnersDavid Risinger$35515% downsideOpen
2026-02-19Barclays$18555.7% downsideOpen
2026-02-19Wells Fargo$37510.3% downsideOpen
2026-02-18Piper Sandler$4323.4% upsideOpen
2026-02-11Mizuho Securities$29529.4% downsideOpen
2026-02-04RBC Capital$36013.8% downsideOpen
2026-02-04Morgan Stanley$30926% downsideOpen
2026-01-29Oppenheimer$4004.3% downsideOpen
2026-01-26UBS$3906.7% downsideOpen
2026-01-20BernsteinMarket Perform$33519.8% downsideOpen
2026-01-06UBS$3809.1% downsideOpen
2025-12-12Morgan Stanley$30427.2% downsideOpen
2025-12-10HSBC$4251.7% upsideOpen
2025-12-03BMO CapitalEvan Seigerman$37211% downsideOpen
2025-11-25Wells Fargo$4004.3% downsideOpen
2025-11-24Truist Financial$31823.9% downsideOpen
2025-11-14Piper SandlerDavid Amsellem$3818.8% downsideOpen
2025-11-06Cantor Fitzgerald$31524.6% downsideOpen
2025-11-05Wells Fargo$30028.2% downsideOpen
2025-08-25Piper Sandler$34218.2% downsideOpen
2025-05-02UBSTrung Huynh$31524.6% downsideOpen
2025-04-22Cantor Fitzgerald$30527% downsideOpen
2025-03-05Johnson Rice$29429.6% downsideOpen
2024-11-12JefferiesMichael Yee$3809.1% downsideOpen
2024-11-12Cantor FitzgeraldOlivia Brayer$4053.1% downsideOpen
2024-10-21Morgan StanleyTerence Flynn$31923.7% downsideOpen
2024-10-16Goldman SachsSalveen Richter$36911.7% downsideOpen

AMGEN (AMGN) FAQ

AMGEN's target price stands at $370. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

The Street's average target of $370 for AMGN implies 11.0% downside versus today's price ($417.84). Positive implied upside usually reflects optimism on growth or margins, while a large downside can signal valuation or fundamental concerns. Check recommendation mix and recent target changes for more context.

The history chart shows how AMGEN's target price evolved across reporting periods, while the comparison chart places AMGN next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, target price is commonly used to spot outliers. AMGEN's reading of $370 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.